Project: Nano-motion based rapid antimicrobial susceptibility testing to PREVENt sepSIS and fight AMR
Acronym | PREVENSIS (Reference Number: 113912) |
Duration | 01/06/2020 - 01/06/2023 |
Project Topic | We will finalise the development of a rapid antimicrobial susceptibility testing diagnostic technology, R-AST, and deliver a device and consumable package ready for CE-IVD mark. R-AST will allow clinicians to prescribe efficient antibiotic therapy for urgent treatment of sepsis. Our approach based on proprietary nano-motion technology to detect bacterial response to antibiotics is significantly faster than current methods therefore enables timely specific treatments to reduce sepsis mortality. |
Network | Eurostars 2 |
Call | Eurostars Cut–off 12 |